Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area ubiquitination proteasome ubiquitination'

Search results for: 'research area ubiquitination proteasome ubiquitination'

Items 1-10 of 12

Page
per page
  1. Nocodazole
    A8487 Nocodazole
     1 Citation
    Target: Microtubules/Tubulins
    Summary: Tubulin production inhibitor,anti-neoplastic agent
      insoluble in H2O; insoluble in EtOH; ≥15.066 mg/mL
  2. LY 294002
    A8250 LY 294002
     16 Citation
    Target: PI3K
    Summary: Potent PI3K inhibitor
  3. MG-262
    A8179 MG-262
     1 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor
      ≥24.57 mg/mL
  4. Bortezomib (PS-341)
    A2614 Bortezomib (PS-341)
     24 Citation
    Target: Proteasome
    Summary: Proteasome Inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.21 mg/mL
  5. MG-132
    A2585 MG-132
     26 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor, Cell permeable, reversible
      ≥23.78 mg/mL
  6. Cathepsin S inhibitor
    A3284 Cathepsin S inhibitor
     1 Citation
    Target: Cathepsins
    Summary: Blocks MHCII antigen presentation
      ≥24.25 mg/mL
  7. LDN 57444
    A4003 LDN 57444
    Target: UCH
    Summary: UCH-L1 inhibitor,reversible competitve
      insoluble in EtOH; insoluble in H2O; ≥16.7 mg/mL
  8. Saxagliptin
    A8650 Saxagliptin
    Target: DPP-4
    Summary: Selective DPP4 inhibitor
  9. MK-0752
    A4006 MK-0752
     1 Citation
    Summary: γ-secretase inhibitor
      ≥22.15 mg/mL
  10. SID 26681509
    A4424 SID 26681509
    Target: Cathepsins
    Summary: Human cathepsin L inhibitor,potent and reversible
      <26.98 mg/mL

Items 1-10 of 12

Page
per page